Impaired Vascular Endothelial Growth Factor A and Inflammation in Patients with Peripheral Artery Disease

Angiology

Volumn 65, Issue 8, 2014, Pages 683-690

  Gardner, Andrew W ^a,b   Parker, Donald E ^c   Montgomery, Polly S ^a   Sosnowska, Danuta ^a   Casanegra, Ana I ^c   Esponda, Omar L ^c   Ungvari, Zoltan ^a   Csiszar, Anna ^a   Sonntag, William E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

claudication; inflammation; peripheral artery disease; vascular endothelial growth factor A

Indexed keywords

BIOLOGICAL MARKER; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ADULT; ANKLE BRACHIAL INDEX; APOPTOSIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; INFLAMMATION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TREADMILL TEST; WALKING;

CLAUDICATION; INFLAMMATION; PERIPHERAL ARTERY DISEASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

AGED; AGED, 80 AND OVER; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84905911046     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713501376     Document Type: Article

References (52)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics - 2012 update: a report from the American heart association. Circulation. 2012 ; 125 (1). 188-197
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American association of cardiovascular and pulmonary rehabilitation; National heart, lung, and blood institute; society for vascular nursing; TransAtlantic inter-society consensus; and vascular disease foundation. Circulation. 2006 ; 113 (11). e463 - e654
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007 ; 45 (suppl S). S5 - S67
4. Brass EP, Hiatt WR. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med. 2006 ; 11 (3). 141-145
5. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 ; 326 (6). 381-386
6. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008 ; 13 (3). 209-215
7. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991 ; 23 (4). 402-408
8. Hiatt WR, Nawaz D, Regensteiner JG, Hossack KF.. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulmonary Rehabil. 1988 ; 12: 525-532
9. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001 ; 286 (13). 1599-1606
10. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004 ; 292 (4). 453-461
11. McDermott MM, Liu K, O'Brien E, et al. Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer. Angiology. 2000 ; 51 (2). 91-100
12. Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med. 1997 ; 2 (4). 286-291
13. Ware JE. The status of health assessment 1994. Annu Rev Public Health. 1995 ; 16: 327-354
14. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the walking and leg circulation study. Ann Intern Med. 2002 ; 136 (12). 873-883
15. Davignon J, Ganz P.. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004 ; 109 (23 suppl 1). III27 - III32
16. Barbato JE, Tzeng E. Nitric oxide and arterial disease. J Vasc Surg. 2004 ; 40 (1). 187-193
17. Healy B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol. 1990 ; 16 (2). 357-358
18. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994 ; 24 (6). 1468-1474
19. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993 ; 88 (5 Pt 1). 2149-2155
20. Jarvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004 ; 109 (14). 1750-1755
21. Maldonado FJ, Miralles Jde H, Aguilar EM, Gonzalez AF, Garcia JR, Garcia FA. Relationship between noninvasively measured endothelial function and peripheral arterial disease. Angiology. 2009 ; 60 (6). 725-731
22. Schroeder S, Enderle MD, Ossen R, et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J. 1999 ; 138 (4 pt 1). 731-739
23. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000 ; 86 (2). 207-210
24. Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol. 1999 ; 83 (5). 754-758
25. Gardner AW, Montgomery PS, Parker DE. Metabolic syndrome impairs physical function, health-related quality of life, and peripheral circulation in patients with intermittent claudication. J Vasc Surg. 2006 ; 43 (6). 1191-1196
26. Signorelli SS, Mazzarino MC, Di Pino L, et al. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med. 2003 ; 8 (1). 15-19
27. Kals J, Kampus P, Kals M, et al. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens. 2006 ; 19 (9). 902-908
28. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011 ; 123 (5). 491-498
29. Lohman TC, Roche AF, Marubini E Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books ; 1988: 39-70.
30. Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley diabetes study. J Clin Epidemiol. 1990 ; 43 (6). 597-606
31. Gardner AW. Reliability of transcutaneous oximeter electrode heating power during exercise in patients with intermittent claudication. Angiology. 1997 ; 48 (3). 229-235
32. Feinberg RL, Gregory RT, Wheeler JR, et al. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg. 1992 ; 16 (2). 244-250
33. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009 ; 297 (5). H1876 - H1881
34. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 2010 ; 299 (1). H18 - H24
35. Ungvari Z, Bailey-Downs L, Gautam T, et al. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011 ; 300 (4). H1133 - H1140
36. Csiszar A, Labinskyy N, Perez V, et al. Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol. 2008 ; 295 (5). H1882 - H1894
37. Csiszar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev. 2009 ; 130 (8). 518-527
38. Ungvari Z, Ridgway I, Philipp EE, et al. Extreme longevity is associated with increased resistance to oxidative stress in Arctica islandica, the longest-living non-colonial animal. J Gerontol A Biol Sci Med Sci. 2011 ; 66 (7). 741-750
39. Bailey-Downs LC, Sosnowska D, Toth P, et al. Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese Lewis dwarf rats: implications for vascular aging. J Gerontol A Biol Sci Med Sci. 2012 ; 67 (6). 553-564
40. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2012 ; 67 (4). 313-329
41. Csiszar A, Labinskyy N, Zhao X, et al. Vascular superoxide and hydrogen peroxide production and oxidative stress resistance in two closely related rodent species with disparate longevity. Aging Cell. 2007 ; 6 (6). 783-797
42. Ungvari Z, Bailey-Downs L, Gautam T, et al. Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta. J Gerontol A Biol Sci Med Sci. 2011 ; 66 (8). 866-875
43. Torres JL, Ridker PM. High sensitivity C-reactive protein in clinical practice. Am Heart Hosp J. 2003 ; 1 (3). 207-211
44. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol. 2001 ; 87 (3). 324-329
45. Kirk G, Hickman P, McLaren M, Stonebridge PA, Belch JJ. Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD). Eur J Vasc Endovasc Surg. 1999 ; 18 (5). 434-438
46. Gardner AW, Alaupovic P, Parker DE, Montgomery PS, Roof A, Casanegra AI. Apolipoprotein profiles in subjects with and without peripheral artery disease. Vasc Med. 2013 ; 18 (3). 129-135
47. Gardner AW, Parker DE, Montgomery PS, Blevins SM, Teague AM, Casanegra AI. Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication. Angiology. 2014 ; 65: 491-496
48. Gavin TP, Drew JL, Kubik CJ, Pofahl WE, Hickner RC. Acute resistance exercise increases skeletal muscle angiogenic growth factor expression. Acta Physiol (Oxf). 2007 ; 191 (2). 139-146
49. Waters RE, Rotevatn S, Li P, Annex BH, Yan Z. Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am J Physiol Cell Physiol. 2004 ; 287 (5). C1342 - C1348
50. Hoier B, Rufener N, Bojsen-Moller J, Bangsbo J, Hellsten Y. The effect of passive movement training on angiogenic factors and capillary growth in human skeletal muscle. J Physiol. 2010 ; 588 (pt 19). 3833-3845
51. Hansen AH, Nielsen JJ, Saltin B, Hellsten Y. Exercise training normalizes skeletal muscle vascular endothelial growth factor levels in patients with essential hypertension. J Hypertens. 2010 ; 28 (6). 1176-1185
52. Jones WS, Duscha BD, Robbins JL, et al. Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training. Vasc Med. 2012 ; 17 (2). 94-100